Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


XANTHOPOULOS KLEANTHIS G Create: Alert

All | News | Filings
Date FiledTypeDescription
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2020 4 XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 7,500 shares @ $0
06/05/2020 4 XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 15,000 options to buy @ $1.01, valued at $15.2k
07/18/2019 4 XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 1,500 options to buy @ $2.34, valued at $3.5k
06/01/2018 4 XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 25,000 options to buy @ $4.24, valued at $106k
03/02/2018 4 XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 30,000 options to buy @ $0
01/08/2018 4 XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on APRICUS BIOSCIENCES, INC.
Txns: Granted 50,000 options to buy @ $2.11, valued at $105.5k
01/06/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
11/04/2016 4 XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on Zosano Pharma Corp
10/03/2016 4 XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on APRICUS BIOSCIENCES, INC.
Txns: Granted 16,997 shares @ $0.3383, valued at $5.8k
07/01/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
04/07/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/21/2013 4 XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on APRICUS BIOSCIENCES, INC.
Txns: Sold 2,864 shares @ $2.52, valued at $7.2k
04/22/2013 4 XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on APRICUS BIOSCIENCES, INC.
Txns: Sold 2,864 shares @ $2.627, valued at $7.5k
03/21/2013 4 XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on APRICUS BIOSCIENCES, INC.
Txns: Sold 2,864 shares @ $2.5, valued at $7.2k
01/08/2013 4 XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on APRICUS BIOSCIENCES, INC.
Txns: Granted 16,000 options to buy @ $2.1, valued at $33.6k
10/04/2012 3 XANTHOPOULOS KLEANTHIS G (President & CEO) has filed a Form 3 on Regulus Therapeutics Inc.
10/01/2012 4 XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on APRICUS BIOSCIENCES, INC.
Txns: Sold 3,125 shares @ $3.2506, valued at $10.2k
08/17/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
01/04/2012 4 XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on APRICUS BIOSCIENCES, INC.
Txns: Granted 16,000 options to buy @ $0
11/21/2011 4 Form 4 - Statement of changes in beneficial ownership of securities
11/21/2011 3 Form 3 - Initial statement of beneficial ownership of securities
05/27/2011 4 XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on ANADYS PHARMACEUTICALS INC
Txns: Granted 15,000 options to buy @ $1.17, valued at $17.6k
05/28/2010 4 XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on ANADYS PHARMACEUTICALS INC
Txns: Granted 15,000 options to buy @ $2.3, valued at $34.5k
05/29/2009 4 XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on ANADYS PHARMACEUTICALS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy